论文部分内容阅读
【关键词】孟鲁司特;沙美特罗替卡松粉剂;支气管哮喘
【中图分类号】R562.25 【文献标识码】B 【文章编号】1002-8714（2019）12-0005-02
【Objective】to investigate the pharmaceutical analysis of salmeteroticasone powder in the treatment of bronchial asthma. Method in February 2018 to February 2019 in our hospital during the period of treatment of 118 cases of patients with bronchial asthma in income order divided into two groups， 59 patients before setting as the reference group， 59 cases were set to the team， after the former using a single meng LuSi treatment， which is based on the combined salmeterol assigned powder treatment， compared two groups of therapeutic effect. Results the total effective rate was 96.61% in the research group and 84.75% in the reference group， with statistically significant data （P
【中图分类号】R562.25 【文献标识码】B 【文章编号】1002-8714（2019）12-0005-02
【Objective】to investigate the pharmaceutical analysis of salmeteroticasone powder in the treatment of bronchial asthma. Method in February 2018 to February 2019 in our hospital during the period of treatment of 118 cases of patients with bronchial asthma in income order divided into two groups， 59 patients before setting as the reference group， 59 cases were set to the team， after the former using a single meng LuSi treatment， which is based on the combined salmeterol assigned powder treatment， compared two groups of therapeutic effect. Results the total effective rate was 96.61% in the research group and 84.75% in the reference group， with statistically significant data （P